US Broker Ratings

Natera, Inc. (NTRA) Stock Analysis: Exploring a 30% Upside Potential Amid Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has caught the attention of investors with its..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 29% Upside with Robust Revenue Growth

Molina Healthcare Inc (NYSE: MOH), with a market capitalization of $8.5 billion, is a prominent player in the U.S. healthcare sector, specifically within the healthcare plans..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 14.31% Potential Upside in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, operates as a leading plasma therapeutic company with a robust international presence. Headquartered in Barcelona, Spain,..

McKesson Corporation (MCK) Stock Analysis: A 17% Upside Potential in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is garnering significant attention as investors weigh its robust market position against a backdrop of compelling..

Ascendis Pharma A/S (ASND) Stock Analysis: A 31% Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector should take a closer look at Ascendis Pharma A/S (NASDAQ: ASND), a dynamic company headquartered in Hellerup,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Exploring the Volatility and Growth Potential

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a company encapsulated in an intriguing mix of promise and volatility. Operating in the healthcare sector, specifically within the..

Repligen Corporation (RGEN) Stock Analysis: Navigating a Potential 61% Upside in the Bioprocessing Space

Repligen Corporation (NASDAQ: RGEN) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, Repligen..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring Growth Potential with a Robust 64.87% Return on Equity

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the Healthcare sector, particularly in Diagnostics & Research, continues to capture investor attention with its notable performance..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 40% Potential Upside for Investors

Globus Medical, Inc. (NYSE: GMED), a prominent name in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a compelling potential..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unlocking a 21% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has increasingly caught the attention of investors seeking opportunities in the medical instruments and..

argenx SE (ARGX) Stock Analysis: Exploring a 21.71% Potential Upside Amid Strong Revenue Growth

argenx SE (ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its significant market presence and promising growth prospects. Based..

Verona Pharma plc (VRNA) Stock Analysis: Riding High on a 52-Week Surge, But Is the Upside Limited?

Verona Pharma plc (VRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its remarkable price performance over the past year...

Elanco Animal Health (ELAN) Stock Analysis: Exploring Growth Potential and Investor Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specializes in the development and marketing of products for pet and farm animal..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating a Potential Upside Amidst Healthcare Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the medical devices industry, is drawing attention from investors with its robust market presence and..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 32.91% Upside Potential Amid Biotech Innovations

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its mission to develop transformative medicines for genetic diseases and cancers. With a..

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings and 10% Upside Potential

Insmed Incorporated (NASDAQ: INSM) continues to capture investor attention with its robust development pipeline and compelling analyst ratings. Operating in the competitive biotechnology sector, Insmed is..

Novo Nordisk A/S (NVO) Investor Outlook: Analyzing a 32.82% Potential Upside in the Healthcare Sector

Novo Nordisk A/S (NVO), a Danish pharmaceutical giant, stands as a formidable player in the Healthcare sector, specifically within the drug manufacturing industry. With a commanding..

The Cigna Group (CI) Investor Outlook: Capitalizing on a 33.71% Potential Upside in Healthcare

The Cigna Group (NYSE: CI), a titan in the healthcare sector, stands out not just for its robust market presence but also for its striking potential..

Amgen Inc. (AMGN) Investor Outlook: Robust Free Cash Flow and a 9.29% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, has consistently demonstrated resilience and innovation within the drug manufacturing industry. With a market capitalization of..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 20% Potential Upside Amidst Mixed Ratings

Illumina, Inc. (NASDAQ: ILMN), a leading player in the diagnostics and research industry, is currently drawing attention from investors due to its potential upside of 20.05%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds